Explore the latest in gynecologic cancer, including recent advances in the management of cervical, endometrial, and ovarian cancers.
This case-control cohort study compares the total number of opioid pain medications prescribed after gynecologic and abdominal surgery, the number of requests for opioid prescription refills, and postoperative pain scores and complications before and after implementation of an ultrarestrictive opioid prescription protocol.
This cohort study compares proportions of women in provincial prison vs women in the general population who were up-to-date for cervical cancer screening between 2006 and 2013 in Ontario, Canada.
This Viewpoint reviews the benefits and risks of risk-reducing mastectomy in otherwise healthy women with BRCA1 and BRCA2 mutations to inform discussions about the proceeding with or foregoing the procedure, and it calls for continued research to understand how to better individualize risk and prevent disease nonsurgically.
This nested case-control study of patients enrolled in Kaiser Permanente Washington quantifies the risk of malignant ovarian cancer based on ultrasonographic characteristics of ovarian masses, including simple cysts, in a large unselected population.
This phase 1 and 2 clinical trial examines progression-free survival in patients with ovarian or breast cancer treated with alisertib in combination with paclitaxel vs paclitaxel alone.
This prospective cohort study evaluates the 5-year risk of cervical precancer following p16/ki-67 dual-stain triage of HPV-positive women.
This cohort study uses data from the Nurses’ Health Studies to evaluate associations between use of nonsteroidal anti-inflammatory drugs and risk of epithelial ovarian cancer.
This cross-sectional study investigates the ascertainment of pathogenic and likely pathogenic BRCA1/2 variants among US adults enrolled in the MyCode Community Health Initiative.
This randomized clinical trial compares the extent of treatment with chemotherapy and radiotherapy in women with locally advanced cervical cancer who have staging using fludeoxyglucose F 18 positron emission–computed tomography along with conventional staging with CT of the abdomen and pelvis vs those who have staging with CT alone.
This registry-based cohort study using data from the Surveillance, Epidemiology, and End Results (SEER) database investigates the risk of human papillomavirus (HPV)–associated second primary cancers among survivors of HPV-associated index cancers and tests the hypothesis that the risk of HPV-associated second primary cancer has increased over the last 4 decades.
In this Medical News article, researchers discuss the outlook for developing effective therapeutic vaccines to treat ovarian cancer.
This systematic review and meta-analysis assesses the prevalence of postmenopausal bleeding among women with endometrial cancer and the risk of endometrial cancer in women with postmenopausal bleeding.
This cohort study investigates overall survival among patients with newly diagnosed metastatic cervical cancer who received chemotherapy alone compared with those who received chemotherapy and pelvic radiation therapy.
This JAMA Patient Page describes the US Preventive Services Task Force’s recommendations on screening for cervical cancer.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: